Rhythm Pharmaceuticals (RYTM) Current Leases (2019 - 2025)
Historic Current Leases for Rhythm Pharmaceuticals (RYTM) over the last 7 years, with Q3 2025 value amounting to $624000.0.
- Rhythm Pharmaceuticals' Current Leases changed N/A to $624000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $624000.0, marking a year-over-year change of. This contributed to the annual value of $770000.0 for FY2023, which is 1257.31% up from last year.
- Per Rhythm Pharmaceuticals' latest filing, its Current Leases stood at $624000.0 for Q3 2025.
- Rhythm Pharmaceuticals' 5-year Current Leases high stood at $816000.0 for Q2 2024, and its period low was $224000.0 during Q1 2025.
- For the 5-year period, Rhythm Pharmaceuticals' Current Leases averaged around $638235.3, with its median value being $644000.0 (2022).
- Its Current Leases has fluctuated over the past 5 years, first skyrocketed by 1355.24% in 2021, then tumbled by 7175.28% in 2025.
- Over the past 5 years, Rhythm Pharmaceuticals' Current Leases (Quarter) stood at $606000.0 in 2021, then increased by 12.87% to $684000.0 in 2022, then increased by 12.57% to $770000.0 in 2023, then rose by 5.97% to $816000.0 in 2024, then dropped by 23.53% to $624000.0 in 2025.
- Its last three reported values are $624000.0 in Q3 2025, $510000.0 for Q2 2025, and $224000.0 during Q1 2025.